MedTrace Logo

Does Perineural Dexamethasone Increase the Duration of an Ulnar Nerve Block When Controlling for Systemic Effects?

NCT04817982 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2021-07-01

No results posted yet for this study

Summary

Investigators will assess if perineural dexamethasone can increase the duration of an ulnar nerve block when controlling for systemic effects in healthy volunteers.

Conditions

  • Anesthesia, Local

Interventions

DRUG

Perineural dexamethasone

Dexamethasone 4mg will be added perineurally to an ulnar nerve block with bupivacaine.

DRUG

Lidocaine

Lidocaine 40 mg will be added perineurally to an ulnar nerve block with bupivacaine.

DRUG

Placebo

Saline will be added perineurally to an ulnar nerve block with bupivacaine.

DRUG

Systemic dexamethasone

Dexamethasone will be added perineurally to an ulnar nerve block with bupivacaine, some will be reabsorbed and distributed systemically. Thereby, the investigators control for the systemic effects of adding perineural dexamethasone to an ulnar nerve block.

Sponsors & Collaborators

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Mathias Maagaard, MD · Zealand University Hospital, Køge

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-07
Primary Completion
2021-05-15
Completion
2021-05-15

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04817982 on ClinicalTrials.gov